Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Informations

Home » Informations
  • Dr. Minghua Zheng’s Team: AI-Based Digital Pathology Provides New Insights into NASH Fibrosis Reversal Induced by Lifestyle Intervention

    Non-Alcoholic Steatohepatitis (NASH) is a common cause of chronic liver disease, and the degree of liver fibrosis is an important factor determining its clinical prognosis. Lifestyle intervention is the cornerstone of NASH treatment and can improve liver fibrosis. However, the specific effects of lifestyle intervention on micro-level liver fibrosis reversal are not clear. Dr. Minghua…

    2024.01.22
  • Tumor Cell-Released Kynurenine Biases MEP Differentiation into Megakaryocytes in Individuals with Cancer: A Novel Mechanism for Thrombocytosis and Erythrocytopenia

    Thrombocytosis and erythrocytopenia are common hematological abnormalities observed in individuals with advanced cancer. However, the underlying molecular mechanisms for these conditions remain largely unknown. In this study, we aimed to…

    2024.01.22
  • Targeting Gut Microbial Nitrogen Recycling for Bortezomib Resistance in Multiple Myeloma

    Multiple myeloma (MM) is a challenging hematological malignancy characterized by the proliferation of malignant plasma cells. Drug resistance and relapse remain major obstacles in the treatment of MM, emphasizing the…

    2024.01.22
  • Deciphering STING-Driven Platelet Activation in Septic Thrombosis: A Comprehensive Study Unveiling Molecular Mechanisms and Therapeutic Avenues

    Sepsis, a life-threatening condition marked by an overwhelming immune response to infection, often leads to severe complications, including septic thrombosis. Recent studies have uncovered the involvement of the STING (Stimulator…

    2024.01.22
  • Single-Cell Dissection of Human Hematopoietic Reconstitution after Allogeneic Hematopoietic Stem Cell Transplantation

    Hematopoietic stem cell transplantation (HSCT) is a regenerative therapy used to treat various malignant, inherited, or autoimmune diseases. Despite its success, the understanding of hematopoietic reconstitution in transplant patients remains…

    2024.01.22
  • The Complexity of Diffuse Large B-Cell Lymphoma: A Revolutionary Genetic Subtyping Algorithm

    Diffuse large B-cell lymphoma (DLBCL), the most prevalent subtype of non-Hodgkin’s lymphoma, presents a significant challenge in its treatment due to its molecular heterogeneity. Despite advancements in immunochemotherapy, a substantial…

    2024.01.22
  • The Role of PD-1 Signaling in T-Cell Acute Lymphoblastic Leukemia: A Revolutionary Breakthrough

    T-cell acute lymphoblastic leukemia (T-ALL) emerges as a formidable adversary within the spectrum of blood cancers, marked by the rapid proliferation of immature T-cell progenitors. The imperative to unravel the…

    2024.01.22
  • Multi-Omics Blood Atlas Reveals Unique Features of Immune and Platelet Responses to SARS-CoV-2 Omicron Breakthrough Infection

    The COVID-19 pandemic caused by SARS-CoV-2 has affected millions of people worldwide. The emergence of new variants, such as Omicron, has raised concerns about the effectiveness of immune responses and…

    2024.01.22
«previous next»
Recent Posts
  • The Search for the “Optimal Surgical Approach” in Advanced Ovarian Cancer: Professor Xiwa Zhao on Individualizing Cytoreductive Surgery
  • National Multicenter CHANCE2504 Study: HAIC Combined with Immunotherapy and Targeted Therapy Significantly Improves Survival in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus
  • Professor Heinz-Josef Lenz: Breaking Through the Barriers to Immunotherapy in Colorectal Cancer and Exploring New Paths to Precision Treatment for MSI and MSS Disease | CSCO 2026
  • Professor Yanhong Deng: Precision and Accessibility Go Hand in Hand—China-Developed Panitumumab N01 Opens a New Era of Fully Human Anti-EGFR Antibodies in mCRC
  • CSCO 2026 Global Perspectives | Professor William Gradishar: From Dual HER2 Blockade to the ADC Era—The Future and Transformation of HER2-Positive Breast Cancer Treatment
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top